Home Stocks Can 2025 J.P. Morgan Healthcare Conference spark biotech M&A

Can 2025 J.P. Morgan Healthcare Conference spark biotech M&A

by Deidre Salcido
0 comments

pcess609/iStock via Getty Images

As top pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Conference next week, biotech dealmaking will be in focus as the annual event usually coincides with major M&A announcements.

With Big Pharma facing significant patent

You may also like

Leave a Comment

About Us

Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stockscryptocurrencyreal estate, finance, and much more.

© 2025 AI Investor Picks – All Rights Reserved

AI Investor Picks